| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Paediatrics (R.W.J.L., P.O., L.K.M.H., A.A.H., A.C.S.H.-K.), Division of Endocrinology, Erasmus Medical Centre-Sophia, Childrens Hospital, 3015 GJ Rotterdam, The Netherlands; and Department of Epidemiology and Biostatistics (T.S.), Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands
Address all correspondence and requests for reprints to: R. W. J. Leunissen, Erasmus MC/Sophia Childrens Hospital, Room Sb 2670, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands. E-mail: r.leunissen{at}erasmusmc.nl.
Background/Objectives: Low birth weight and postnatal catch-up growth have been associated with an increased risk for diabetes mellitus type II (DMII). We evaluated the contribution of birth and adult size, body composition, and waist-to-hip ratio to DMII risk factors in young adulthood.
Methods: In a group of 136 young adults, aged 18–24 yr, insulin sensitivity and disposition index were determined by frequent sampling iv glucose tolerance test. The association of clinical parameters with these variables was analyzed with multiple regression modeling. In addition, differences in insulin sensitivity and disposition index, a measure for β-cell function, were analyzed in four subgroups, young adults either born small for gestational age SGA with short stature (n = 25) or SGA with catch-up growth (n = 23) or born appropriate for gestational age with idiopathic short stature (n = 23) or with normal stature (controls) (n = 26).
Results: Fat mass was the only significant predictor of insulin sensitivity, whereas birth length and birth weight were not significant. After correction for age, gender, and adult body size, insulin sensitivity was significantly lower in subjects born SGA with catch-up growth compared with controls. None of the variables had a significant influence on disposition index, and there was no significant difference in disposition index between the subgroups.
Conclusions: Our data show that a higher body fat mass at 21 yr is associated with reduced insulin sensitivity, independent of birth size. These findings have important implications for public health practice.
This article has been cited by other articles:
![]() |
R. W. J. Leunissen, G. F. Kerkhof, T. Stijnen, and A. Hokken-Koelega Timing and Tempo of First-Year Rapid Growth in Relation to Cardiovascular and Metabolic Risk Profile in Early Adulthood JAMA, June 3, 2009; 301(21): 2234 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. van der Kaay, C. Deal, S. de Kort, R. Willemsen, R. Leunissen, W. Ester, J. Paquette, J. van Doorn, and A. Hokken-Koelega Insulin-Like Growth Factor-Binding Protein-1: Serum Levels, Promoter Polymorphism, and Associations with Components of the Metabolic Syndrome in Short Subjects Born Small for Gestational Age J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1386 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. J. Leunissen, G. F. Kerkhof, T. Stijnen, and A. C. S. Hokken-Koelega Fat Mass and Apolipoprotein E Genotype Influence Serum Lipoprotein Levels in Early Adulthood, whereas Birth Size Does Not J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4307 - 4314. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Beardsall, S. Vanhaesebrouck, A. L. Ogilvy-Stuart, C. Vanhole, C. R. Palmer, M. van Weissenbruch, P. Midgley, M. Thompson, M. Thio, L. Cornette, et al. Early Insulin Therapy in Very-Low-Birth-Weight Infants N. Engl. J. Med., October 30, 2008; 359(18): 1873 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beltrand, R. Verkauskiene, R. Nicolescu, O. Sibony, P. Gaucherand, D. Chevenne, O. Claris, and C. Levy-Marchal Adaptive Changes in Neonatal Hormonal and Metabolic Profiles Induced by Fetal Growth Restriction J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4027 - 4032. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Willemsen, S. P. Willemsen, and A. C. S. Hokken-Koelega Longitudinal Changes in Insulin Sensitivity and Body Composition of Small-For-Gestational-Age Adolescents after Cessation of Growth Hormone Treatment J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3449 - 3454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |